Related Experiment Video
Updated: Dec 11, 2025

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
Published on: September 15, 2018
Cascade screening and treatment of children with familial hypercholesterolemia in Turkey
Engin Kose1, Melis Kose1, Sureyya Ipek Ozturk2
1Department of Pediatric Metabolism and Nutrition, Katip Celebi University Faculty of Medicine, Izmir, Turkey.
Insights
Screening children for familial hypercholesterolemia (FH) is vital for early detection and treatment. Lipid-lowering treatments, including statins, are effective, but challenges in treatment initiation persist.
Area of Science:
- Cardiology
- Genetics
- Pediatrics
Background:
- Familial hypercholesterolemia (FH) is a common genetic disorder leading to premature coronary artery disease.
- Early detection and management of FH are crucial for preventing cardiovascular events.
- A national lipid screening program for school-age children was established in Turkey in 2016.
Purpose of the Study:
- To evaluate the effectiveness of a lipid screening program for identifying children with FH.
- To assess the efficacy of lipid-lowering treatments, including diet and statins, in pediatric FH patients.
- To identify challenges associated with initiating and adhering to FH treatments in children.
Main Methods:
- Retrospective evaluation of pediatric patients diagnosed with FH.
- Assessment of lipid profiles following dietary interventions and statin therapy.
- Analysis of cascade screening results in families of diagnosed children.
Main Results:
- Fifty-one children with FH (mean age 9.8 years) were included; all had heterozygous LDLR gene mutations.
- Dietary intervention led to a 14.5% decrease in LDL-C levels.
- Statin treatment reduced mean LDL-C from 204.1 mg/dL to 137.0 mg/dL, with 15.7% of parents refusing statin initiation.
- Cascade screening identified FH in 13.7% of parents and led to new treatment for relatives.
Conclusions:
- Pediatric FH screening is essential for early diagnosis in children and their families.
- Diet and statins effectively lower LDL-C in children with FH.
- Significant resistance to initiating statin therapy was observed, highlighting a key challenge in management.
Abstract:
Objectives Premature coronary artery disease is the most common preventable cause of death in developed countries, and familial hypercholesterolemia (FH) is the most common monogenetic disorder of lipid metabolism, predisposing for premature coronary artery. FH is the most common preventable cause of death in developed countries. In 2016, the national lipid screening program in school-age children has been started in Turkey. In this study, we aimed to evaluate the efficacy of lipid screening program, lipid-lowering treatments, and the challenges of treatments in children diagnosed with FH. Methods Patients diagnosed with FH in the pediatric metabolism outpatient clinic were retrospectively evaluated. Changes in lipid profile with dietary interventions and statin treatments were assessed. The results of cascade screening were analyzed. Results Fifty-one patients diagnosed with FH were enrolled in the study. Twenty-four (47.1%) were female. The mean age of the patients was 9.8 ± 3.2 years. Heterozygous LDLR gene mutation was detected in all patients. Three novel pathogenic variations were revealed with the genetic investigation. Forty-one (80.4%) patients had high adherence to CHILD-2 dietary recommendations. The mean low-density lipoprotein cholesterol (LDL-C) level decreased by 14.5 ± 7.6% after dietary intervention. Parents refused to start statin treatment in 8 (15.7%) patients. Statin treatment was initiated to 22 (43.1%) patients. Mean LDL-C level decreased from 204.1 ± 19.1 mg/dL to 137.0 ± 13.1 mg/dL. In cascade screening, 7 (13.7%) parents without a diagnosis of FH were diagnosed with FH. After the screening program, statin treatment was initiated for 18 (35.3%) parents and 7 (16.3%) siblings. Conclusions We can conclude that screening for FH in children is crucial for diagnosing FH not only in children but also in their relatives. Although statins are safe and effective in achieving the target LDL-C level, we determined significant resistance for initiating statin treatment in patients.
Related Concept Videos
Atherosclerosis III: Management
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Cholesterol: Significance and Regulation
Considering cholesterol and...
Cystic Fibrosis: Management
Sinus disease and chronic...
Lipids: Dietary Sources and Requirements
Preventive Healthcare Services

